Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Diabetes, Obesity and Metabolism
Published October 27, 2026
Conditional Associations of ApoB and LDL-C With Incident Type 2 Diabetes in UK Biobank: A Prospec...
October 27, 2026
Medspoke
Medspoke
Diabetes, Obesity and Metabolism
Published October 27, 2026
00:00
--:--
Efficacy and Safety of CagriSema in Type 2 Diabetes: A Dose- and Comparator-Specific Systematic R...
October 27, 2026
Share
Efficacy and Safety of CagriSema in Type 2 Diabetes: A Dose- and Comparator-Specific Systematic Review and Bayesian Meta-Analysis.
https://www.medspoke.co/channel_journal?id=804&tap_id=16369
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Annals of Oncology
Published October 25, 2026
Pembrolizumab with or without platinum-based chemotherapy as first-line treatment in advanced NSC...
October 26, 2026
Why are you reporting this TALK?
